Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Cancer. 2016 Aug 16;122(23):3697–3704. doi: 10.1002/cncr.30241

Table 2.

Discovery cohort, replication cohort, and fixed-effects meta-analysis pooled results for maternal SNPs rs12365708 (MTL5, 11q13.2-q13.3), rs6496 (ALKBH1, 14q24.3), and rs4536103 (NEUROG3, 10q21.3).

Discovery cohort1 Replication cohort2 Pooled estimate

SNP MAF RR (95% CI) P MAF RR (95% CI) P RR (95% CI) P
rs12365708 0.13 2.62 (1.61-4.27) 1.86×10−5 0.06 1.36 (0.54-3.44) 0.52 2.27 (1.48-3.50) 1.99×10−4
rs6494 0.06 3.77 (1.84-7.74) 3.73×10−5 0.09 1.38 (0.67-2.87) 0.38 2.31 (1.38-3.85) 0.001
rs4536103 0.38 1.75 (1.30-2.37) 1.17×10−4 0.41 1.46 (0.89-2.41) 0.14 1.67 (1.29-2.16) 9.23×10−5
1

The discovery cohort was comprised of 312 families: 108 case-parent trios, 148 case-parent duos, 32 cases alone, 7 mother-father pairs, and 17 parent singletons.

2

The replication cohort was comprised of 152 families: 15 case-parent trios, 96 parent-child duos, 25 cases alone, 4 mother-father pairs, and 12 singleton parents